PeptideNerds

Selank

Cognitive Research Only moderate evidence Track This Protocol
Alejandro Reyes

Written by Alejandro Reyes

Founder & Lead Researcher

PN

Reviewed by Peptide Nerds Editorial · Updated April 2026

Key Takeaway

Selank is a synthetic analog of the immunomodulatory peptide tuftsin with anxiolytic and nootropic properties, approved for clinical use in Russia.

Quick Facts
Type Cognitive
FDA Status Research Only
Evidence Level Moderate
Typical Dose 200-400 mcg daily
Frequency Once or twice daily intranasal
Key Goals cognitive

How it works

Modulates GABA, serotonin, and dopamine systems. Enhances BDNF expression and has immunomodulatory effects via tuftsin pathway.

Benefits

  • Anxiety reduction
  • Cognitive enhancement
  • Immune modulation
  • Approved in Russia

Side effects

  • Fatigue
  • Nasal irritation
  • Generally well-tolerated

Dosing protocol

Typical Dose

200-400 mcg daily

Frequency

Once or twice daily intranasal

Available as nasal spray. Often used alongside Semax.

Deeper on Selank

Full breakdowns of every part of the Selank research base.

What you will need

Basic supplies for reconstitution and subcutaneous injection.

This page contains affiliate links. Learn more

Get the Selank cheat sheet

Dosing quick-reference, key studies, and side effect management — in your inbox.

Get the Selank cheat sheet

Dosing quick-reference, key studies, and side effect management — in your inbox.

Compare Selank

Stacks with Selank

Goals

Related peptides

Looking for weight loss peptides? See our complete guide to the best peptides for weight loss or compare semaglutide vs tirzepatide .

Get the Peptide Starter Kit (free)

Quick-start guide to GLP-1 peptides, dosing basics, and what to ask your doctor.

Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional medical consultation, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide protocol.